BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandez D, Kirou KA. What Causes Lupus Flares? Curr Rheumatol Rep 2016;18:14. [PMID: 26951252 DOI: 10.1007/s11926-016-0562-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Heine LK, Benninghoff AD, Ross EA, Rajasinghe LD, Wagner JG, Lewandowski RP, Richardson AL, Li Q, Buchweitz JP, Zyskowski J, Tindle AN, Skedel AE, Chargo NJ, Mccabe LR, Harkema JR, Pestka JJ. Comparative effects of human-equivalent low, moderate, and high dose oral prednisone intake on autoimmunity and glucocorticoid-related toxicity in a murine model of environmental-triggered lupus. Front Immunol 2022;13:972108. [DOI: 10.3389/fimmu.2022.972108] [Reference Citation Analysis]
2 Askanase AD, Furie RA. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus. Adv Ther 2022. [PMID: 35641860 DOI: 10.1007/s12325-022-02160-y] [Reference Citation Analysis]
3 Kostopoulou M, Ugarte-Gil MF, Pons-Estel B, van Vollenhoven RF, Bertsias G. The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus. Lupus 2022;:9612033221074580. [PMID: 35067068 DOI: 10.1177/09612033221074580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hurtado C, Rojas-gualdrón D, Hernández D, Díaz JC, Urrego R, Vásquez-trespalacios EM, Pineda R, Vásquez G. Construcción de un cuestionario para caracterizar exposiciones ambientales en pacientes con lupus eritematoso sistémico. Revista Colombiana de Reumatología 2021;28:255-266. [DOI: 10.1016/j.rcreu.2020.07.012] [Reference Citation Analysis]
5 Hurtado C, Rojas-gualdrón D, Hernández D, Díaz JC, Urrego R, Vásquez-trespalacios EM, Pineda R, Vásquez G. Construction of a questionnaire to characterize environmental exposures in patients with systemic lupus erythematosus. Revista Colombiana de Reumatología (English Edition) 2021;28:255-266. [DOI: 10.1016/j.rcreue.2020.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Popis M, Konwerska A, Partyka M, Wieczorkiewicz M, Ciesiółka S, Stefańska K, Spaczyńska J, Golkar-narenji A, Jeseta M, Bukowska D, Mozdziak P, Dyszkiewicz-konwińska M. Mesenchymal stem cells and their secretome - candidates for safe and effective therapy for systemic lupus erythematosus. Medical Journal of Cell Biology 2021;9:110-122. [DOI: 10.2478/acb-2021-0016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gile JJ, Sara JDS, Mueller MR. Systemic lupus erythematosus multiorgan flare with quiescent serologic markers. BMJ Case Rep 2021;14:e239048. [PMID: 33653839 DOI: 10.1136/bcr-2020-239048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Joo YB, Kim KJ, Park KS, Park YJ. Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization. Sci Rep 2021;11:4630. [PMID: 33633288 DOI: 10.1038/s41598-021-84153-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Thanou A, Jupe E, Purushothaman M, Niewold TB, Munroe ME. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers. J Autoimmun 2021;119:102615. [PMID: 33631651 DOI: 10.1016/j.jaut.2021.102615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
10 El-shafey AM, Kamel LM, Fikry AA, Nasr MM, Abdel Galil SM. Serum hepcidin and interleukin-6 in systemic lupus erythematosus patients: crucial factors for correction of anemia. Egypt Rheumatol Rehabil 2020;47:14. [DOI: 10.1186/s43166-020-00006-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Luo KL, Yang YH, Lin YT, Hu YC, Yu HH, Wang LC, Chiang BL, Lee JH. Differential parameters between activity flare and acute infection in pediatric patients with systemic lupus erythematosus. Sci Rep 2020;10:19913. [PMID: 33199770 DOI: 10.1038/s41598-020-76789-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Sun F, Geng S, Wang H, Wang H, Liu Z, Wang X, Li T, Wan W, Lu L, Teng X, Morel L, Ye S. Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials. Lupus Sci Med 2020;7:e000429. [PMID: 33093216 DOI: 10.1136/lupus-2020-000429] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
13 Webb M, Sideris DP. Intimate Relations-Mitochondria and Ageing. Int J Mol Sci 2020;21:E7580. [PMID: 33066461 DOI: 10.3390/ijms21207580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
14 Allen ME, Rus V, Szeto GL. Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies. Trends Mol Med 2021;27:152-71. [PMID: 33046407 DOI: 10.1016/j.molmed.2020.09.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
15 Raghavan S, Gonakoti S, Asemota IR, Mba B. A Case of Systemic Lupus Erythematosus Flare Triggered by Severe Coronavirus Disease 2019. J Clin Rheumatol 2020;26:234-5. [PMID: 32826658 DOI: 10.1097/RHU.0000000000001531] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
16 Maharani W, Ratnaningsih DF, Utami F, Yulianto FA, Dewina A, Hamijoyo L, Atik N. Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results. J Inflamm Res 2020;13:433-9. [PMID: 32884324 DOI: 10.2147/JIR.S258235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Babini A, Cappuccio AM, Caprarulo C, Casado G, Eimon A, Figueredo H, García MA, Magri S, Mannucci P, Perez Rodriguez S, Pons-Estel BA, Velozo EJ, Iglesias-Rodriguez M, Streger G. Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina. Lupus 2020;29:1385-96. [PMID: 32791930 DOI: 10.1177/0961203320947814] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Bell CF, Lau M, Lee M, Poulos C. Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE. Clin Rheumatol 2021;40:581-90. [PMID: 32623647 DOI: 10.1007/s10067-020-05226-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 van Vollenhoven RF, Navarra SV, Levy RA, Thomas M, Heath A, Lustine T, Adamkovic A, Fettiplace J, Wang ML, Ji B, Roth D. Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension. Rheumatology (Oxford) 2020;59:281-91. [PMID: 31302695 DOI: 10.1093/rheumatology/kez279] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
20 Tiosano S, Nir Z, Gendelman O, Comaneshter D, Amital H, Cohen A, Amital D. The association between systemic lupus erythematosus and bipolar disorder – a big data analysis. Eur psychiatr 2017;43:116-9. [DOI: 10.1016/j.eurpsy.2017.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
21 Benli M, Batool F, Stutz C, Petit C, Jung S, Huck O. Orofacial manifestations and dental management of systemic lupus erythematosus: A review. Oral Dis 2021;27:151-67. [PMID: 31886584 DOI: 10.1111/odi.13271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
22 Lucas RM, Yazar S, Young AR, Norval M, de Gruijl FR, Takizawa Y, Rhodes LE, Sinclair CA, Neale RE. Human health in relation to exposure to solar ultraviolet radiation under changing stratospheric ozone and climate. Photochem Photobiol Sci 2019;18:641-80. [PMID: 30810559 DOI: 10.1039/c8pp90060d] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 32.0] [Reference Citation Analysis]
23 Ahmed HM, Abohamad S, Elfishawi M, Hegazy MT, Vijaykumar K. Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction. Patient Prefer Adherence. 2018;12:2475-2479. [PMID: 30538431 DOI: 10.2147/ppa.s147163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wan SJ, Lara-Corrales I. Sun Protection in Pediatric Patients With Rheumatic Disease. Clin Pediatr (Phila) 2019;58:140-5. [PMID: 30264580 DOI: 10.1177/0009922818802632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Charles N, Chemouny JM, Daugas E. Basophil involvement in lupus nephritis: a basis for innovation in daily care. Nephrology Dialysis Transplantation 2019;34:750-6. [DOI: 10.1093/ndt/gfy245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zaalberg A, Moradi Tuchayi S, Ameri AH, Ngo KH, Cunningham TJ, Eliane JP, Livneh M, Horn TD, Rosman IS, Musiek A, Anadkat MJ, Demehri S. Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus. J Invest Dermatol 2019;139:62-70. [PMID: 30030152 DOI: 10.1016/j.jid.2018.06.185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
27 Martínez-García EA, Zavala-Cerna MG, Lujano-Benítez AV, Sánchez-Hernández PE, Martín-Márquez BT, Sandoval-García F, Vázquez-Del Mercado M. Potential Chronotherapeutic Optimization of Antimalarials in Systemic Lupus Erythematosus: Is Toll-Like Receptor 9 Expression Dependent on the Circadian Cycle in Humans? Front Immunol 2018;9:1497. [PMID: 30034390 DOI: 10.3389/fimmu.2018.01497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Furie RA, Wallace DJ, Aranow C, Fettiplace J, Wilson B, Mistry P, Roth DA, Gordon D. Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States. Arthritis Rheumatol 2018;70:868-77. [PMID: 29409143 DOI: 10.1002/art.40439] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
29 Pascoe K, Lobosco S, Bell D, Hoskin B, Chang DJ, Pobiner B, Ramachandran S. Patient- and Physician-reported Satisfaction With Systemic Lupus Erythematosus Treatment in US Clinical Practice. Clin Ther 2017;39:1811-26. [PMID: 28803702 DOI: 10.1016/j.clinthera.2017.07.039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Capalbo G, Leccese I, Bogdanos D, Spinelli FR, Alessandri C, Valesini G, Conti F. Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment. Seminars in Arthritis and Rheumatism 2017;47:53-64. [DOI: 10.1016/j.semarthrit.2017.03.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
31 Thong B, Olsen NJ. Systemic lupus erythematosus diagnosis and management. Rheumatology (Oxford). 2017;56:i3-i13. [PMID: 28013206 DOI: 10.1093/rheumatology/kew401] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]